IQ Capital β 2023 Investments
6 investments dated 2023 Β· listed companies and verified rows first Β· show all
Quadsat develops modular radio-frequency sensing and electronic warfare payloads (such as SpectraLoc) that integrate into UAV platforms for RF signal detection and emitter geolocation, along with spectrum operations software.
Deep TechDefense TechHardwareSpace TechOdense, DK
Co-investorsJoin CapitalSeraphim SpaceExport and Investment Fund
Dreamfold engineers proteins as therapeutic medicines, using generative AI models that reason over protein sequence and structure to enable potent, localized immune modulation with minimal off-target effects.
AI & Machine LearningBiotechMedical Devices
Co-investorsOpenOceanPanache Ventures
Mindgard provides AI security solutions that help enterprises identify, assess, and mitigate threats across AI models, agents, and applications throughout the AI lifecycle.
AI & Machine LearningCybersecurityEnterprise SoftwareBoston, US
Dr. Peter GarraghaninJames Brear(CEO)inAaron Portnoy(Head of Research)inRich Smith(Offensive Security Lead)in
Co-investors.406 VenturesAtlantic Bridge VenturesOsney CapitalAlbum VCKarma VenturesLakestar
Mytos develops automated manufacturing technology for regenerative medicines, specifically targeting the production of stem cell-derived therapies to make treatments for conditions like Parkinson's, blindness, and spinal cord injury accessible and affordable to patients.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical DevicesRoboticsLondon, GB
Ali Afshar(Founder/CEO)inIgnacio Willats(Founder)in
Co-investorsY CombinatorAcequia Capital (AceCap)Artis VenturesDeep Science VenturesEmles Venture PartnersKinled Holding+4 more
Paragraf develops graphene-based electronic devices, including molecular sensors (electrolyte-gated field-effect transistors) for biosensing and chemical sensing, and Hall effect sensors for current, position, and magnetic field measurement at cryogenic temperatures.
Deep TechNew MaterialsSemiconductorsCambridgeshire
Simon Thomas(Chief Executive Officer of the issuer.)
Co-investorsAmadeus Capital PartnersBlack Opal VenturesCambridge Angels groupEMV CapitalIn-Q-TelMartlet Capital+4 more
Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.
BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh
Richard Izen Kuo(Executive Officer, Director)Joanna Smart(Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)
Co-investorsEos Advisory
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.